Search research articles
Contact Us
Filters
Showing results (81-90 of 120) with videos related to
Page
of 12
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 13, 2016
Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment
Goki Suda, Atsushi Nagasaka, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 10, 2018
Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction
Takuya Sho, Goki Suda, Atsushi Nagasaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 30, 2022
Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients
Machiko Umemura, Koji Ogawa, Kenichi Morikawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 21, 2020
Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria
Takuya Sho, Goki Suda, Koji Ogawa, et al.
Frontiers in Genetics
|
May 23, 2022
Case Report: Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia
Michiko Takimoto-Sato, Toshinari Miyauchi, Masaru Suzuki, et al.
Alimentary Pharmacology & Therapeutics
|
September 4, 2024
Positivity of high-sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non-HBV-related HCC
Naohiro Yasuura, Goki Suda, Masatsugu Ohara, et al.
Scientific Reports
|
October 7, 2022
Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy
Naoki Kawagishi, Goki Suda, Ryotaro Sakamori, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 15, 2020
Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting
Takuya Sho, Goki Suda, Koji Ogawa, et al.
Scientific Reports
|
November 29, 2025
Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort
Goki Suda, Masaru Baba, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 10, 2021
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria
Takuya Sho, Goki Suda, Koji Ogawa, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 120) with videos related to
Sort By:
Page
of 12
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 13, 2016
Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment
Goki Suda, Atsushi Nagasaka, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 10, 2018
Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction
Takuya Sho, Goki Suda, Atsushi Nagasaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 30, 2022
Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients
Machiko Umemura, Koji Ogawa, Kenichi Morikawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 21, 2020
Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria
Takuya Sho, Goki Suda, Koji Ogawa, et al.
Frontiers in Genetics
|
May 23, 2022
Case Report: Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia
Michiko Takimoto-Sato, Toshinari Miyauchi, Masaru Suzuki, et al.
Alimentary Pharmacology & Therapeutics
|
September 4, 2024
Positivity of high-sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non-HBV-related HCC
Naohiro Yasuura, Goki Suda, Masatsugu Ohara, et al.
Scientific Reports
|
October 7, 2022
Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy
Naoki Kawagishi, Goki Suda, Ryotaro Sakamori, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 15, 2020
Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting
Takuya Sho, Goki Suda, Koji Ogawa, et al.
Scientific Reports
|
November 29, 2025
Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort
Goki Suda, Masaru Baba, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 10, 2021
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria
Takuya Sho, Goki Suda, Koji Ogawa, et al.
Page
of 12